Sign In
Free Newsletter
Former MD CEO charged with insider trading tied to COVID vaccine contamination
An ex-executive of Gaithersburg-based Emergent BioSolutions was charged with selling stock while knowing about problems at a Baltimore plant.
Moore touts MD apprenticeship progress surpassing 2025 goal
Maryland's chief executive said the state engaged more than 500 businesses and institutions to recruit 5,200 new apprentices in 2025.
AstraZeneca to invest $2B in MD as part of manufacturing push
AstraZeneca will invest $2B to expand biologics manufacturing in Frederick and build a facility in Gaithersburg, creating hundreds of jobs.
Maryland STEM Festival inspires next generation of innovators
Maryland STEM Festival kicks off Oct. 17, offering 300+ events statewide to inspire students and grow Maryland’s future STEM workforce.
AstraZeneca opens $300M cell therapy site in Rockville
AstraZeneca opened a $300M CAR-T cell therapy facility in Rockville, boosting Maryland's life sciences sector and creating 150+ high-skilled jobs.
Howard University receives $10M grant for public service law
Welcome to Monday, the 86th anniversary of the first night Major League Baseball game. Here are some news items to start your week. — Howard University School of Law receives […]
With $250M from investors, Viela Bio out on its own
MedImmune spun out Viela Bio as an independent biotechnology company with $250 million in Series A financing and six potential medicines, the companies announced Wednesday. Viela Bio will be based […]
AstraZeneca to pay $7.9 million over kickback allegations
The Justice Department says pharmaceutical manufacturer AstraZeneca will pay $7.9 million to settle allegations it engaged in a kickback scheme involving drugs such as heartburn medicines Nexium and Prilosec.
AstraZeneca to expand, add 300 jobs in Frederick
The company is investing $200 million to expand its biologics manufacturing center.
Md. lawmakers worried about AstraZeneca jobs
Maryland's two U.S. senators and four of the state's eight representatives are urging drug maker Pfizer Inc. to make sure that its proposed merger with AstraZeneca PLC doesn't eliminate Maryland jobs.
MedImmune expands partnership with USM
Gaithersburg-based MedImmune is expanding its recently announced research partnership with the University of Maryland, Baltimore to include two more UM campuses: College Park and Baltimore County.
Md. company to study cancer medicine feasibility
ROCKVILLE — A Rockville company will study the feasibility of a new cancer medicine with the large pharmaceutical company AstraZeneca. CytImmune Sciences Inc. and AstraZeneca made the announcement on Thursday. […]
